venBio Global Strategic Fund II L.P. → Menlo Therapeutics Inc. VYNE

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.00

183,974 shares short · +76.3% vs prior

Other Filings by venBio Global Strategic Fund II L.P.

Filed	Form	Issuer	Stake	Shares
2021-05-07	SC	Akero Therapeutics, Inc.	—	—	view →
2020-09-09	SC	Akero Therapeutics, Inc.	—	—	view →
2020-01-15	SC	Akero Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →